PeptideDB

(±)-Leucine-d10 (DL-Leucine-d10; (RS)-Leucine-d10) 29909-01-1

(±)-Leucine-d10 (DL-Leucine-d10; (RS)-Leucine-d10) 29909-01-1

CAS No.: 29909-01-1

(±)-Leucine-d10 is the deuterated form of (±)-Leucine. (±)-Leucine (DL-Leucine), an isomer of leucine, is a chemical
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

(±)-Leucine-d10 is the deuterated form of (±)-Leucine. (±)-Leucine (DL-Leucine), an isomer of leucine, is a chemical bactericide and dietary additive. (±)-Leucine suppresses the growth of E. coli by 92.08%.

Physicochemical Properties


Molecular Formula C6H3D10NO2
Molecular Weight 141.23
Exact Mass 141.157
CAS # 29909-01-1
Related CAS # (±)-Leucine;328-39-2
PubChem CID 16213561
Appearance White to off-white solid powder
Density 1.0±0.1 g/cm3
Boiling Point 225.8±23.0 °C at 760 mmHg
Melting Point 293-296ºC (subl.)(lit.)
Flash Point 90.3±22.6 °C
Vapour Pressure 0.0±0.9 mmHg at 25°C
Index of Refraction 1.463
LogP 0.73
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 3
Heavy Atom Count 9
Complexity 101
Defined Atom Stereocenter Count 0
SMILES

[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])C([2H])([2H])C([2H])(C(=O)O)N

InChi Key ROHFNLRQFUQHCH-SHJFKSRGSA-N
InChi Code

InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/i1D3,2D3,3D2,4D,5D
Chemical Name

2-amino-2,3,3,4,5,5,5-heptadeuterio-4-(trideuteriomethyl)pentanoic acid
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro Drug compounds have included stable heavy isotopes of carbon, hydrogen, and other elements, mostly as quantitative tracers while the drugs were being developed. Because deuteration may have an effect on a drug's pharmacokinetics and metabolic properties, it is a cause for concern [1].
References

[1]. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

[2]. Attractiveness of tobacco budworm females altered by oral chemosterilants and dietary additives. Journal of Chemical Ecology. 1977 Mar; 127-131.


Solubility Data


Solubility (In Vitro) H2O : 12.5 mg/mL (88.51 mM)
Solubility (In Vivo) Solubility in Formulation 1: 10 mg/mL (70.81 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 7.0806 mL 35.4032 mL 70.8065 mL
5 mM 1.4161 mL 7.0806 mL 14.1613 mL
10 mM 0.7081 mL 3.5403 mL 7.0806 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.